Sitagliptin attenuates the progression of coronary atherosclerosis in patients with coronary disease and type 2 diabetes
Bo Li, Yanrong Luo, Feng Tian, Yundai Chen, Jinwen Tian, Yu Ding, Zhu Mei, Jingwei Li, Ying-Qian Zhang, Weiming Shi
Topics & Concepts
SitagliptinMedicineInternal medicineCoronary artery diseaseAtheromaCardiologyCoronary atherosclerosisDiabetes mellitusPercutaneous coronary interventionClinical endpointType 2 diabetesDipeptidyl peptidase-4 inhibitorRandomized controlled trialMyocardial infarctionEndocrinologyDiabetes Treatment and ManagementBlood Pressure and Hypertension StudiesCoronary Interventions and Diagnostics